EUVIMEDExplore EUVIMED
CrossrefInfo card

Occupational Allergic Contact Dermatitis due to Rubber Additives in Tunisia: A 27‐Year Retrospective Study of Clinical and Occupational Characteristics

Emna Baraketi, Jihen Hsinet, Nihel Khouja, Aida Benzarti

Contact Dermatitis · 2026-12 · 95 (6) · 566-575

DOI: 10.1111/cod.70253 ↗
AbstractBibliographic details

Abstract

ABSTRACT Background Rubber additives are established causes of occupational allergic contact dermatitis (OACD), but data from North Africa are scarce. Objectives To characterize OACD due to rubber additives in a Tunisian tertiary referral population and assess its impact on fitness for work. Methods A retrospective study included all adult patients diagnosed with OACD to rubber additives between 1998 and 2025. Patch testing was performed with the European baseline series, with additional rubber series in selected cases. Clinical, occupational and allergological data were analysed. Associations with MOAHLFA index and temporal trends were assessed using logistic regression. Results Eighty patients were included. Thiurams were the most frequent sensitizers (74%), followed by benzothiazole derivatives (24%) and p‐phenylenediamine derivatives (14%). The healthcare sector predominated (51%) and gloves were the main exposure source (88%). Sensitization to multiple rubber additive families occurred in 19% of cases. No significant associations were found with MOAHLFA index after adjustment and no significant temporal trends were observed. Workplace adaptation was required in all cases and OACD met criteria for compensation as an occupational disease in 92%. Conclusions OACD due to rubber additives remains frequent and is associated with a substantial occupational impact, emphasizing the need for preventive measures.

Knowledge that fits your work.

From a free start through personal literature research to the complete Research Suite.

View plans →

Are all publisher full texts included?

No. Bibliographic records, abstracts and full texts are different content types. Full-text availability depends on the source, open access and your existing licences. An EUVIMED plan does not replace additional publisher rights.

View plans →